Contact

All Stories

  1. Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial

    Article • Nature Reports Stem Cells, November 2025, Springer Science + Business Media

    Prof james O'Beirne

  2. Models of care for the management of cirrhosis: a global review

    Article • Frontline Gastroenterology, September 2025, BMJ

    Prof james O'Beirne

  3. Cause‐specific mortality among Queensland people with cirrhosis, by cirrhosis aetiology and decompensation status, 2007–22: a retrospective cohort study

    Article • The Medical Journal of Australia, September 2025, Wiley

    Prof james O'Beirne

  4. A population-based study of cause-specific mortality in First Nations Australians with cirrhosis: impact of cardiometabolic comorbidities and liver disease risk factors

    Article • The Lancet Regional Health - Western Pacific, August 2025, Elsevier

    Prof james O'Beirne

  5. THU-418 The effect of a fast-food meal on endothelial function in people with metabolic dysfunction-associated steatotic fatty liver desease

    Article • Journal of Hepatology, May 2025, Elsevier

    Prof james O'Beirne

  6. Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD trial)

    Article • BMC Health Services Research, March 2025, Springer Science + Business Media

    Prof james O'Beirne

  7. High Fibrosis-4 is Associated With Increased Risk of Cirrhosis Decompensation and Liver-Related Mortality in at-Risk Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease

    Article • Gastro Hep Advances, January 2025, Elsevier

    Prof james O'Beirne

  8. Parallel randomised trial testing community fibrosis assessment for suspected non-alcoholic fatty liver disease: outcomes from LOCATE-NAFLD

    Article • BMJ Open Gastroenterology, December 2024, BMJ

    Prof james O'Beirne

  9. Nursing

    Article • Journal of Gastroenterology and Hepatology, September 2024, Wiley

    Prof james O'Beirne

  10. An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and Considerations

    Article • Patient Preference and Adherence, September 2024, Taylor & Francis

    Prof james O'Beirne

  11. A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC)

    Article • BMC Cancer, July 2024, Springer Science + Business Media

    Prof james O'Beirne

  12. Australians with metabolic dysfunction‐associated steatotic liver disease have a twofold increase in the incidence of cancer

    Article • JGH Open, July 2024, Wiley

    Prof james O'Beirne

  13. Rising hospital admissions for alcohol-related cirrhosis and the impact of sex and comorbidity – a data linkage study

    Article • Public Health, July 2024, Elsevier

    Prof james O'Beirne

  14. Implementation of a nurse-delivered, community-based liver screening and assessment program for people with non-alcoholic fatty liver disease (LOCATE-NAFLD trial)

    Article • May 2024, Springer Science + Business Media

    Prof james O'Beirne

  15. High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia

    Article • International Journal for Equity in Health, April 2024, Springer Science + Business Media

    Prof james O'Beirne

  16. Indications and outcomes of transjugular intrahepatic portosystemic shunt insertion in two regional Australian hepatology centres

    Article • Internal Medicine Journal, April 2024, Wiley

    Prof james O'Beirne

  17. Transforming global hepatology training: a call for action

    Article • The Lancet Gastroenterology & Hepatology, March 2024, Elsevier

    Prof james O'Beirne

  18. A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, Australia

    Article • Public Health, March 2024, Elsevier

    Prof james O'Beirne

  19. A parallel randomised trial testing community fibrosis assessment for suspected non-alcoholic fatty liver disease: Outcomes from LOCATE-NAFLD

    Article • February 2024, Springer Science + Business Media

    Prof james O'Beirne

  20. Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysis

    Article • Hepatology Communications, January 2024, Wolters Kluwer Health

    Prof james O'Beirne

  21. Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists

    Article • Annals of Hepatology, November 2023, Elsevier

    Prof james O'Beirne

  22. Diabetes mellitus and the progression of non‐alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study

    Article • The Medical Journal of Australia, September 2023, Wiley

    Prof james O'Beirne

  23. Letter to the Editor: The impact of a paracentesis education program among junior doctors

    Article • Liver Transplantation, September 2023, Wolters Kluwer Health

    Prof james O'Beirne

  24. A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels

    Article • BMC Health Services Research, September 2023, Springer Science + Business Media

    Prof james O'Beirne

  25. Hepatology Clinical

    Article • Journal of Gastroenterology and Hepatology, August 2023, Wiley

    Prof james O'Beirne

  26. A Discrete Choice Experiment to Elicit Preferences for a Liver Screening Programme in Queensland, Australia: A Mixed Methods Study to Select Attributes and Levels

    Article • November 2022, Research Square

    Prof james O'Beirne

  27. Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus

    Article • Hepatology Communications, September 2022, Wolters Kluwer Health

    Thomas Tu, Prof james O'Beirne

  28. Hepatology Clinical

    Article • Journal of Gastroenterology and Hepatology, September 2022, Wiley

    Prof james O'Beirne

  29. Retreatment for hepatitis C virus direct‐acting antiviral therapy virological failure in primary and tertiary settings: The REACH‐C cohort

    Article • Journal of Viral Hepatitis, May 2022, Wiley

    Prof james O'Beirne

  30. Global multi-stakeholder endorsement of the MAFLD definition

    Article • The Lancet Gastroenterology & Hepatology, May 2022, Elsevier

    Dr Feliciano C Paquissi, Professor Sandro Vento, Dr. Francesca Cainelli, Prof. Dr. Mahmoud ElFiky, Dr Arif Mansur Cosar, Dr Amalia Gastaldelli, Dr Nazarii Kobyliak, Prof james O'Beirne

  31. Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes

    Article • BMC Health Services Research, April 2022, Springer Science + Business Media

    Prof james O'Beirne

  32. The fate of indeterminate liver lesions: What proportion are precursors of hepatocellular carcinoma?

    Article • BMC Gastroenterology, March 2022, Springer Science + Business Media

    Prof james O'Beirne

  33. The role of a novel self-expanding metal stent in variceal bleeding: a multicenter Australian and New Zealand experience

    Article • Endoscopy International Open, March 2022, Thieme Publishing Group

    Prof james O'Beirne

  34. An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care

    Article • Diabetic Medicine, February 2022, Wiley

    Prof james O'Beirne

  35. Assessment of clinically significant portal hypertension by two‐dimensional shear wave elastography

    Article • European Journal of Clinical Investigation, January 2022, Wiley

    Prof james O'Beirne

  36. Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach

    Article • Cancers, November 2021, MDPI AG

    Prof james O'Beirne

  37. Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography

    Article • Digestive Diseases and Sciences, November 2021, Springer Science + Business Media

    Prof james O'Beirne

  38. High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an Australian Real‐World Cohort: The REACH‐C Study

    Article • Hepatology Communications, November 2021, Wolters Kluwer Health

    Prof james O'Beirne

  39. Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort

    Article • International Journal of Drug Policy, October 2021, Elsevier

    Prof james O'Beirne

  40. Late breaker posters

    Article • Journal of Hepatology, July 2021, Elsevier

    Prof james O'Beirne

  41. Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis

    Article • Internal Medicine Journal, May 2021, Wiley

    Prof james O'Beirne

  42. Performance of simple serum‐based tests to exclude cirrhosis prior to hepatitis C treatment in non‐hospital settings in Australia

    Article • Internal Medicine Journal, April 2021, Wiley

    Prof james O'Beirne

  43. Is methotrexate hepatotoxicity associated with cumulative dose? A systematic review and meta‐analysis

    Article • Australasian Journal of Dermatology, March 2021, Wiley

    Prof james O'Beirne

  44. One-stop shop for variceal surveillance: integration of unsedated ultrathin endoscopy into the routine clinic visit

    Article • Frontline Gastroenterology, January 2021, BMJ

    Prof james O'Beirne

  45. Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics

    Article • Clinical Infectious Diseases, September 2020, Oxford University Press (OUP)

    Prof james O'Beirne

  46. Letter: pre‐emptive TIPSS for variceal bleeding—patient selection is key

    Article • Alimentary Pharmacology & Therapeutics, July 2020, Wiley

    Prof james O'Beirne

  47. Cost-effectiveness analysis of an outreach model of Hepatitis C Virus (HCV) assessment to facilitate HCV treatment in primary care

    Article • PLOS One, June 2020, PLOS

    Prof james O'Beirne

  48. Transjugular Intrahepatic Portosystemic Shunts for Hepatorenal Syndrome: TIPping the Scales in Whose Favor?

    Article • Digestive Diseases and Sciences, May 2020, Springer Science + Business Media

    Prof james O'Beirne

  49. Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD)

    Article • BMC Health Services Research, April 2020, Springer Science + Business Media

    Prof james O'Beirne

  50. Liver Transplantation for Alcoholic Liver Disease: Absence of Evidence for the Relevance of Abstinence

    Article • Digestive Diseases and Sciences, April 2020, Springer Science + Business Media

    Prof james O'Beirne

  51. Area Under Trough Concentrations of Tacrolimus as a Predictor of Progressive Renal Impairment After Liver Transplantation

    Article • Transplantation, December 2019, Wolters Kluwer Health

    Prof james O'Beirne

  52. Readmission Following Hospitalization for Alcoholic Hepatitis: Costly or Cost-Effective?

    Article • Digestive Diseases and Sciences, September 2019, Springer Science + Business Media

    Prof james O'Beirne

  53. On the path to detecting significant liver disease

    Article • Frontline Gastroenterology, September 2019, BMJ

    Prof james O'Beirne

  54. A stepwise thrombolysis regimen in the management of acute portal vein thrombosis in patients with evidence of intestinal ischaemia

    Article • Alimentary Pharmacology & Therapeutics, September 2019, Wiley

    Prof james O'Beirne

  55. Hepatology Clinical

    Article • Journal of Gastroenterology and Hepatology, September 2019, Wiley

    Prof james O'Beirne

  56. Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease

    Article • BMC Gastroenterology, July 2019, Springer Science + Business Media

    Prof james O'Beirne

  57. Cardiovascular morbidity and mortality is increased post‐liver transplantation even in recipients with no pre‐existing risk factors

    Article • Liver International, July 2019, Wiley

    Prof james O'Beirne

  58. Contemporary Educational Interventions for General Practitioners (GPs) in Primary Care Settings in Australia: A Systematic Literature Review

    Article • Frontiers in Public Health, June 2019, Frontiers

    Prof james O'Beirne

  59. Observational study of the microcirculation in patients with liver cirrhosis

    Article • JGH Open, May 2019, Wiley

    Prof james O'Beirne

  60. Systematic review with meta‐analysis: ultra‐thin gastroscopy compared to conventional gastroscopy for the diagnosis of oesophageal varices in people with cirrhosis

    Article • Alimentary Pharmacology & Therapeutics, May 2019, Wiley

    Prof james O'Beirne

  61. Increasing Hospitalization Rates for Cirrhosis: Overrepresentation of Disadvantaged Australians

    Article • EClinicalMedicine, May 2019, Elsevier

    Prof james O'Beirne

  62. THU-430-Changing prevalence of aetiological factors among Australians hospitalized for cirrhosis

    Article • Journal of Hepatology, April 2019, Elsevier

    Prof james O'Beirne

  63. FRI-202-Outcomes of hepatitis B patients transplanted without hepatitis B immunoglobulin

    Article • Journal of Hepatology, April 2019, Elsevier

    Prof james O'Beirne

  64. THU-431-The burgeoning growth in cirrhosis-related hospitalization in Australia, 2008-2016

    Article • Journal of Hepatology, April 2019, Elsevier

    Prof james O'Beirne

  65. FRI-243-Utility of simple serum based tests to exclude cirrhosis prior to HCV treatment in non-hospital based settings

    Article • Journal of Hepatology, April 2019, Elsevier

    Prof james O'Beirne

  66. Cytomegalovirus viral load parameters associated with earlier initiation of pre-emptive therapy after solid organ transplantation

    Article • PLOS One, January 2019, PLOS

    Prof james O'Beirne

  67. Clinical nurse specialist role in setting up a joint hepatocellular carcinoma clinic at a specialist liver unit

    Article • Gastrointestinal Nursing, December 2018, Mark Allen Group

    Prof james O'Beirne

  68. Hepatitis C treatment in primary care in regional australia

    Article • Frontline Gastroenterology, October 2018, BMJ

    Prof james O'Beirne

  69. Benefit of haemostatic spray in variceal bleeding: early application of spray or early application of guidelines?

    Article • Gut, June 2018, BMJ

    Prof james O'Beirne

  70. Administration of Albumin Solution Increases Serum Levels of Albumin in Patients With Chronic Liver Failure in a Single-Arm Feasibility Trial

    Article • Clinical Gastroenterology and Hepatology, May 2018, Elsevier

    Prof james O'Beirne

  71. Tacrolimus cumulative exposure after liver transplantation is associated with a progressive derangement of renal function despite routine dose adjustments

    Article • Journal of Hepatology, April 2018, Elsevier

    Prof james O'Beirne

  72. The Royal Free Hospital ‘hub-and-spoke network model’ delivers effective care and increased access to liver transplantation

    Article • Public Health, January 2018, Elsevier

    Prof james O'Beirne

  73. What is the role of the microcirculation in liver disease

    Article • Alimentary Pharmacology & Therapeutics, October 2017, Wiley

    Prof james O'Beirne, Thomas Davies

  74. Correction: Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy

    Article • PLOS One, September 2017, PLOS

    Prof james O'Beirne

  75. Correction

    Article • Hepatology, August 2017, Wiley

    Prof james O'Beirne

  76. PTU-104 Maximising access to hcv treatment – the sunshine coast experience

    Article • June 2017, BMJ

    Prof james O'Beirne

  77. PWE-067 Post operative change in albi grade predicts medium term survival in patients undergoing resection for hcc

    Article • June 2017, BMJ

    Prof james O'Beirne

  78. Non-selective beta-blockers are not associated with increased mortality in cirrhotic patients with ascites

    Article • Liver International, March 2017, Wiley

    Dr Emmanuel A Tsochatzis, Maria Kalafateli, Prof james O'Beirne

  79. Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity

    Article • The American Journal of Gastroenterology, February 2017, Springer Science + Business Media

    Prof james O'Beirne

  80. Liver Transplantation

    Article • December 2016, Springer Science + Business Media

    Prof james O'Beirne

  81. Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: The royal free hospital cirrhosis glomerular filtration rate

    Article • Hepatology, November 2016, Wiley

    Prof james O'Beirne

  82. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices

    Article • Journal of Hepatology, November 2016, Elsevier

    Prof james O'Beirne

  83. Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy

    Article • PLOS One, September 2016, PLOS

    Prof james O'Beirne

  84. Elevated liver enzymes in inflammatory bowel disease

    Article • European Journal of Gastroenterology & Hepatology, July 2016, Wolters Kluwer Health

    Prof james O'Beirne, Charles Murray

  85. Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade

    Article • British Journal of Cancer, March 2016, Nature

    Prof james O'Beirne

  86. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score

    Article • Journal of Cachexia Sarcopenia and Muscle, February 2016, Wiley

    Prof james O'Beirne

  87. A la Carte Treatment of Acute Variceal Bleeding

    Article • January 2016, Springer Science + Business Media

    Prof james O'Beirne

  88. Consensus Statements: Management of the Acute Bleeding Episode

    Article • January 2016, Springer Science + Business Media

    Prof james O'Beirne

  89. Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study

    Article • World Journal of Hepatology, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Prof james O'Beirne

  90. An Early Definition of Response to Corticosteroids in Acute Severe Autoimmune Hepatitis

    Article • Journal of Hepatology, January 2016, Elsevier

    Prof james O'Beirne

  91. False-Negative Liver Ultrasound Limits Benefits of HCC Surveillance

    Article • Journal of Hepatology, January 2016, Elsevier

    Prof james O'Beirne

  92. Liver Transplant Care Arranged through “Hub and Spoke” Networks Delivers Comparable Patient Outcomes

    Article • Journal of Hepatology, January 2016, Elsevier

    Prof james O'Beirne

  93. Non-Selective Beta Blockers (NSBBS) Use is Associated with Improved Survival in Cirrhotic Patients with Ascites: A Single Centre Retrospective Study

    Article • Journal of Hepatology, January 2016, Elsevier

    Prof james O'Beirne

  94. Prevalence and Predictors of the Metabolic Syndrome Post Liver Transplantation

    Article • Journal of Hepatology, January 2016, Elsevier

    Prof james O'Beirne

  95. Role of self-expanding metal stents in the management of variceal haemorrhage: Hype or hope?

    Article • World Journal of Gastrointestinal Endoscopy, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Prof james O'Beirne

  96. The Baveno VI Guidelines: Can We Confidently Identify Low Risk Cirrhotic Patients not Requiring Endoscopic Surveillance for Varices?

    Article • Journal of Hepatology, January 2016, Elsevier

    Prof james O'Beirne

  97. The Prevalence and Predictors of Cardiovascular Events Post-Liver Transplantation

    Article • Journal of Hepatology, January 2016, Elsevier

    Prof james O'Beirne

  98. When Is Intensive Care Treatment Futile in Patients with Organ Failure and End-Stage Liver Disease?

    Article • Journal of Hepatology, January 2016, Elsevier

    Prof james O'Beirne

  99. Selection criteria for resection in hepatocellular carcinoma: Can we expand them?

    Article • Hepatology, December 2015, Wiley

    Prof james O'Beirne

  100. Liver transplantation for acute liver failure because of genotype 3 hepatitis E virus infection

    Article • Liver Transplantation, November 2015, Wiley

    Prof james O'Beirne

  101. Individualized care for portal hypertension: Not quite yet

    Article • Journal of Hepatology, September 2015, Elsevier

    Prof james O'Beirne

  102. Synchronous Hepatic Epithelioid Hemangioendothelioma and Hepatocellular Carcinoma

    Article • Medicine, August 2015, Wolters Kluwer Health

    Prof james O'Beirne

  103. PTH-118 Albi score predicts survival in patients with bclc 0/a stage hepatocellular carcinoma (HCC) independently of child pugh (CP) score and treatment allocation

    Article • June 2015, BMJ

    Prof james O'Beirne

  104. PTH-120 Albi score predicts survival independently of hepatic venous pressure gradient (HVPG) and indocyanine green (ICG) clearance in HCC patients undergoing resection

    Article • June 2015, BMJ

    Prof james O'Beirne

  105. PTH-119 Differences between radiology and histopathology: are we judging wrong? should we lower alpha-fetoprotein cut-off in the selection criteria?

    Article • June 2015, BMJ

    Prof james O'Beirne

  106. PTH-134 Reduced calcineurin inhibitor exposure early after liver transplantation protects against renal dysfunction independently of the use of basiliximab induction therapy

    Article • June 2015, BMJ

    Prof james O'Beirne

  107. PWE-092 Systemic tpa for acute splanchnic vein thrombosis

    Article • June 2015, BMJ

    Prof james O'Beirne

  108. PWE-134 Transjugular liver biopsy versus percutaneous liver biopsy – indications, adequacy, quality of specimens and complications

    Article • June 2015, BMJ

    Prof james O'Beirne

  109. P0387 : Identification of optimal cut-offs in alpha-fetoprotein and the “AFP Score” to maximise the accuracy of selection of liver transplant candidates with hepatocellular carcinoma

    Article • Journal of Hepatology, April 2015, Elsevier

    Prof james O'Beirne

  110. P0081 : Reduced calcineurin inhibitor exposure early after liver transplantation protects against renal dysfunction independently of the use of basiliximab induction therapy

    Article • Journal of Hepatology, April 2015, Elsevier

    Prof james O'Beirne

  111. P0178 : Sarcopenia and malnutrition predict early post-liver transplantation outcomes independently of the meld score: implications for organ allocation

    Article • Journal of Hepatology, April 2015, Elsevier

    Prof james O'Beirne

  112. Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade

    Article • Journal of Clinical Oncology, February 2015, American Society of Clinical Oncology (ASCO)

    Prof james O'Beirne

  113. Adrenal insufficiency

    Article • January 2015, Wiley

    Prof james O'Beirne

  114. Lack of agreement for defining ‘clinical suspicion of rejection’ in liver transplantation: a model to select candidates for liver biopsy

    Article • Transplant International, January 2015, Wiley

    Prof james O'Beirne

  115. Beneficial Effect of Intra-Operative Methylprednisolone on Immediate post Liver Transplant Intensive Care Course

    Article • Annals of Transplantation, January 2015, International Scientific Literature

    Prof james O'Beirne

  116. Therapeutic hypothermia in acute liver failure: Not that hot?

    Article • Liver Transplantation, December 2014, Wiley

    Prof james O'Beirne

  117. Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within milan criteria

    Article • Liver Transplantation, October 2014, Wiley

    Prof james O'Beirne

  118. De novouse of generic tacrolimus in liver transplantation - a single center experience with one-yr follow-up

    Article • Clinical Transplantation, October 2014, Wiley

    Prof james O'Beirne

  119. The accuracy of respiratory rate assessment by doctors in a London teaching hospital: a cross-sectional study

    Article • Journal of Clinical Monitoring and Computing, October 2014, Springer Science + Business Media

    Prof james O'Beirne

  120. Inflammation-based scores and hepatocellular carcinoma - authors' reply

    Article • Liver Transplantation, October 2014, Wiley

    Prof james O'Beirne

  121. Embolization of porto-systemic shunt as treatment for recurrent hepatic encephalopathy

    Article • Annals of Hepatology, September 2014, Elsevier

    Prof james O'Beirne

  122. Endoscopy management algorithms: role of cyanoacrylate glue injection and self-expanding metal stents in acute variceal haemorrhage

    Article • Frontline Gastroenterology, June 2014, BMJ

    Prof james O'Beirne

  123. OC-034 Outcome Of Patients Considered Unsuitable For Liver Transplantation – A Missed Opportunity For Palliative Care?

    Article • Gut, June 2014, BMJ

    Prof james O'Beirne

  124. Developmental dysplasia of the hip: incidence and treatment outcomes in the Southeast of Ireland

    Article • Irish Journal of Medical Science (1971 -), May 2014, Springer Science + Business Media

    Prof james O'Beirne

  125. Characteristics of Epstein-Barr viraemia in adult liver transplant patients: A retrospective cohort study

    Article • Transplant International, May 2014, Wiley

    Dr Neil Halliday, Prof james O'Beirne

  126. Letter: prognostic scores in alcoholic hepatitis - authors' reply

    Article • May 2014, Wiley

    Prof james O'Beirne

  127. Generic tacrolimus in solid organ transplantation

    Article • Clinical Transplantation, April 2014, Wiley

    Prof james O'Beirne

  128. Endoprosthetics for bleeding esophageal varices

    Article • Techniques in Gastrointestinal Endoscopy, April 2014, Elsevier

    Prof james O'Beirne

  129. P906 AZATHIOPRINE AND EARLY TACROLIMUS LEVELS <10 ng/mL ARE PROTECTIVE AGAINST PROGRESSIVE FIBROSIS IN RECURRENT HCV POST LT

    Article • Journal of Hepatology, April 2014, Elsevier

    Prof james O'Beirne

  130. P920 DOES PRE-TRANSPLANT ADRENAL FUNCTION HAVE AN IMPACT ON POST-TRANSPLANT RENAL FUNCTION?

    Article • Journal of Hepatology, April 2014, Elsevier

    Prof james O'Beirne

  131. P1302 THE OPTIMAL IMMUNOSUPPRESSION REGIMEN FOR DELAYING FIBROSIS PROGRESSION IN HCV AFTER LIVER TRANSPLANTATION

    Article • Journal of Hepatology, April 2014, Elsevier

    Prof james O'Beirne

  132. Transient residence of a seropositive organ is sufficient to transfer human cytomegalovirus to a seronegative recipient

    Article • Transplant Infectious Disease, March 2014, Wiley

    Prof james O'Beirne

  133. Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort

    Article • Alimentary Pharmacology & Therapeutics, February 2014, Wiley

    Prof james O'Beirne

  134. Anti-tumour necrosis factor agent and liver injury: Literature review, recommendations for management

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Prof james O'Beirne, Charles Murray

  135. Transarterial chemoembolization and bland embolization for hepatocellular carcinoma

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Prof james O'Beirne

  136. Onco-nephrology: Time to Intravasate

    Article • Advances in Chronic Kidney Disease, January 2014, Elsevier

    Prof james O'Beirne

  137. Case Report of Multimodality Treatment for Metastatic Parathyroid Hormone-related Peptide-secreting Pancreatic Neuroendocrine Tumour

    Article • Tumori Journal, January 2014, SAGE Publications

    Prof james O'Beirne

  138. Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma

    Article • Journal of Hepatology, December 2013, Elsevier

    Prof james O'Beirne

  139. Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes

    Article • Gut, October 2013, BMJ

    Prof james O'Beirne

  140. Using an ‘action set’ for the management of acute upper gastrointestinal bleeding

    Article • Therapeutic Advances in Gastroenterology, August 2013, SAGE Publications

    Prof james O'Beirne, Charles Murray

  141. Erratum to: “Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation” [J Hepatol 2013;58:962–968]

    Article • Journal of Hepatology, August 2013, Elsevier

    Prof james O'Beirne

  142. A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer

    Article • Annals of Oncology, July 2013, Oxford University Press (OUP)

    Prof james O'Beirne

  143. Liver transplantation for HIV/HCV coinfection: where is the controversy?

    Article • Future Virology, July 2013, Future Medicine

    Prof james O'Beirne

  144. Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation

    Article • Journal of Hepatology, May 2013, Elsevier

    Prof james O'Beirne

  145. Transarterial chemoembolisation is not superior to embolisation alone: The recent European Association for the Study of the Liver (EASL)–European Organisation for Research and Treatment of Cancer (EORTC) guidelines

    Article • European Journal of Cancer, April 2013, Elsevier

    Prof james O'Beirne

  146. Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma

    Article • Liver International, March 2013, Wiley

    Prof james O'Beirne

  147. A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma

    Article • British Journal of Cancer, February 2013, Springer Science + Business Media

    Prof james O'Beirne

  148. Early tacrolimus exposure after liver transplantation: Relationship with moderate/severe acute rejection and long-term outcome

    Article • Journal of Hepatology, February 2013, Elsevier

    Prof james O'Beirne

  149. Transarterial therapies for hepatocellular carcinoma (HCC): A long way towards standardization

    Article • Journal of Hepatology, January 2013, Elsevier

    Prof james O'Beirne

  150. Resource implications of expanding the use of donation after circulatory determination of death in liver transplantation

    Article • Liver Transplantation, July 2012, Wiley

    Prof james O'Beirne

  151. Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation

    Article • Journal of Gastroenterology and Hepatology, June 2012, Wiley

    Prof james O'Beirne

  152. Liver and pancreatic transplantation

    Article • Anaesthesia & intensive care medicine, June 2012, Elsevier

    Prof james O'Beirne

  153. PTU-021 Do all regenerative nodules become hepatocellular carcinoma? The outcome of 4 years MRI surveillance

    Article • Gut, May 2012, BMJ

    Prof james O'Beirne

  154. PTU-054 Transjugular intrahepatic portosystemic shunts following liver transplantation can be associated with a good prognosis: a single centre experience

    Article • Gut, May 2012, BMJ

    Prof james O'Beirne

  155. Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy

    Article • Arabian archaeology and epigraphy, May 2012, Wiley

    Professor Vincent Emery, Prof james O'Beirne

  156. 714 DO ALL ARTERIALISED NODULES BECOME HEPATOCELLULAR CARCINOMA? THE OUTCOME OF 4 YEARS MAGNETIC RESONANCE IMAGING SURVEILLANCE

    Article • Journal of Hepatology, April 2012, Elsevier

    Prof james O'Beirne

  157. 220 MONITORING BLOOD EOSINOPHILS CAN PREDICT RESPONSE TO CORTICOSTEROIDS IN PATIENTS WITH ACUTE CELLULAR REJECTION AFTER LIVER TRANSPLANTATION

    Article • Journal of Hepatology, April 2012, Elsevier

    Prof james O'Beirne

  158. SOFA score and acetaminophen-induced acute liver failure

    Article • Liver Transplantation, April 2012, Wolters Kluwer Health

    Prof james O'Beirne

  159. 197 TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTS FOLLOWING LIVER TRANSPLANTATION CAN BE ASSOCIATED WITH A GOOD PROGNOSIS: A SINGLE CENTRE EXPERIENCE

    Article • Journal of Hepatology, April 2012, Elsevier

    Prof james O'Beirne

  160. Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure

    Article • Liver Transplantation, March 2012, Wiley

    Prof james O'Beirne

  161. Predicting severity and clinical course of acute rejection after liver transplantation using blood eosinophil count

    Article • Transplant International, March 2012, Wiley

    Prof james O'Beirne

  162. Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2011, New England Journal of Medicine (NEJM/MMS)

    Prof james O'Beirne

  163. P17 TIPS outcomes for Budd-Chiari: a single tertiary centre experience

    Article • Gut, September 2011, BMJ

    Professor Rajiv Jalan, Prof james O'Beirne

  164. OP09 TIPS outcomes for refractory ascites: a single centre experience

    Article • Gut, September 2011, BMJ

    Professor Rajiv Jalan, Prof james O'Beirne

  165. Critical Illness-Related Corticosteroid Insufficiency in Patients With Cirrhosis and Variceal Bleeding

    Article • Clinical Gastroenterology and Hepatology, July 2011, Elsevier

    Prof james O'Beirne

  166. Hepatic Transplantation

    Article • May 2011, Wiley

    Prof james O'Beirne

  167. Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

    Article • The Lancet, April 2011, Elsevier

    Professor Vincent Emery, Prof james O'Beirne

  168. Anaesthesia for caesarean section in a patient with Budd–Chiari syndrome and hepatopulmonary syndrome post liver transplantation

    Article • International Journal of Obstetric Anesthesia, April 2011, Elsevier

    Prof james O'Beirne

  169. There will be blood... a complete audit cycle

    Article • Gut, March 2011, BMJ

    Charles Murray, Prof james O'Beirne

  170. 161 COLLAGEN PROPORTIONATE AREA: BEST INDEX TO PREDICT DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS OF DIFFERENT ETIOLOGIES

    Article • Journal of Hepatology, March 2011, Elsevier

    Prof james O'Beirne

  171. 556 SVR AND TACROLIMUS WITH AZATHIOPRINE IN HCV POST LT PATIENTS WERE ASSOCIATED WITH FIBROSIS REGRESSION BASED ON COLLAGEN PROPORTIONATE AREA

    Article • Journal of Hepatology, March 2011, Elsevier

    Prof james O'Beirne

  172. 569 THE UTILITY OF RADIOISOTOPE BONE SCANS IN LIVER TRANSPLANT ASSESSMENT FOR HCC

    Article • Journal of Hepatology, March 2011, Elsevier

    Prof james O'Beirne

  173. Increased bilirubin following fluid resuscitation with albumin: mechanisms behind an important observation

    Article • Intensive Care Medicine, February 2011, Springer Science + Business Media

    Prof james O'Beirne

  174. Assessment of adrenocortical reserve in stable patients with cirrhosis

    Article • Journal of Hepatology, February 2011, Elsevier

    Prof james O'Beirne

  175. Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C Virus 1 year after liver transplantation

    Article • Liver Transplantation, January 2011, Wiley

    Prof james O'Beirne

  176. Neurogenic diabetes insipidus presenting in a patient with subacute liver failure: a case report

    Article • Journal of Medical Case Reports, July 2010, Springer Science + Business Media

    Prof james O'Beirne

  177. Fulminant Hepatic Failure: Treatment

    Article • July 2010, Wiley

    Prof james O'Beirne

  178. Resource implications of expanding the use of NHBD (non-heart-beating-donors) in liver transplantation

    Article • European Journal of Anaesthesiology, June 2010, Wolters Kluwer Health

    Prof james O'Beirne

  179. Steroids administration during liver transplantion (LT) reduces the need for physiological support post operatively… More evidence for relative adrenal insufficiency in liver failure

    Article • European Journal of Anaesthesiology, June 2010, Wolters Kluwer Health

    Prof james O'Beirne

  180. A randomized phase II/III trial of three weekly cisplatin based transarterial chemoembolization (TACE) versus embolization (TAE) alone for hepatocellular cancer (HCC).

    Article • Journal of Clinical Oncology, May 2010, American Society of Clinical Oncology (ASCO)

    Prof james O'Beirne

  181. Severe, Acute Liver Injury and Khat Leaves

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2010, New England Journal of Medicine (NEJM/MMS)

    Alan Crozier, Prof james O'Beirne

  182. PTU-063 Effect of intra-operative methylprednisolone on post liver transplant intensive care unit course: further evidence for the existence of hepato-adrenal syndrome?

    Article • April 2010, BMJ

    Prof james O'Beirne

  183. PTU-058 Histological liver collagen proportionate area predicts decompensation in patients with liver cirrhosis of mixed aetiologies

    Article • April 2010, BMJ

    Prof james O'Beirne

  184. PTU-074 Infection and history of infection are independent of meld for prognosis in cirrhosis

    Article • April 2010, BMJ

    Prof james O'Beirne

  185. PTU-064 The use of non-heart-beating donor grafts increases perioperative resource utilisation in liver transplantation

    Article • April 2010, BMJ

    Prof james O'Beirne

  186. PTU-059 Which correlation among histological assessment of fibrosis, non-invasive markers and portal hypertension in HCV transplanted patients?

    Article • April 2010, BMJ

    Prof james O'Beirne

  187. 429 ADRENAL INSUFFICIENCY IN PATIENTS WITH CIRRHOSIS AND VARICEAL BLEEDING

    Article • Journal of Hepatology, April 2010, Elsevier

    Prof james O'Beirne

  188. 163 ASSESSMENT OF ADRENOCORTICAL RESERVE IN STABLE PATIENTS WITH CIRRHOSIS

    Article • Journal of Hepatology, April 2010, Elsevier

    Prof james O'Beirne

  189. 162 BACTERIAL INFECTIONS IN CIRRHOSIS ARE ASSOCIATED WITH A POOR PROGNOSIS THAT IS NOT REFLECTED BY MELD AND UKELD SCORES

    Article • Journal of Hepatology, April 2010, Elsevier

    Prof james O'Beirne

  190. 481 CPA MEASUREMENT AT ONE YEAR BIOPSY IS HIGHLY PREDICTIVE OF FUTURE CLINICAL DECOMPENSATION IN HCV POST-TRANSPLANT PATIENTS RANDOMIZED IN TACROLIMUS MONOTHERAPY VERSUS TRIPLE THERAPY (TACROLIMUS-BASED)

    Article • Journal of Hepatology, April 2010, Elsevier

    Prof james O'Beirne

  191. 488 EFFECT OF INTRA-OPERATIVE METHYLPREDNISOLONE ON POST LIVER TRANSPLANT (LT) INTENSIVE CARE UNIT (ITU) COURSE – FURTHER EVIDENCE FOR THE EXISTENCE OF HEPATO-ADRENAL SYNDROME?

    Article • Journal of Hepatology, April 2010, Elsevier

    Prof james O'Beirne

  192. 200 INFECTION AND HISTORY OF INFECTION ARE INDEPENDENT OF MELD FOR PROGNOSIS IN CIRRHOSIS

    Article • Journal of Hepatology, April 2010, Elsevier

    Prof james O'Beirne

  193. 459 THE USE OF NON HEART BEATING DONOR GRAFTS INCREASES PERIOPERATIVE RESOURCE UTILISATION IN LIVER TRANSPLANTATION

    Article • Journal of Hepatology, April 2010, Elsevier

    Prof james O'Beirne

  194. 476 WHICH CORRELATION AMONG HISTOLOGICAL ASSESSMENT OF FIBROSIS, NON-INVASIVE MARKERS AND PORTAL HYPERTENSION IN HCV TRANSPLANTED PATIENTS?

    Article • Journal of Hepatology, April 2010, Elsevier

    Prof james O'Beirne

  195. Critically Ill Patients With Cirrhosis and Low Serum Sodium

    Article • Journal of Clinical Gastroenterology, March 2010, Wolters Kluwer Health

    Prof james O'Beirne

  196. F.N.12 BACTERIAL INFECTIONS IN CIRRHOSIS ARE ASSOCIATED WITH A POOR PROGNOSIS THAT IS NOT REFLECTED BY MELD AND UKELD SCORES

    Article • Digestive and Liver Disease, February 2010, Elsevier

    Prof james O'Beirne

  197. A self-expanding metal stent for complicated variceal hemorrhage: experience at a single center

    Article • Gastrointestinal Endoscopy, January 2010, Elsevier

    Prof james O'Beirne

  198. Generation of functional CD8+ T Cells by human dendritic cells expressing glypican-3 epitopes

    Article • Journal of Experimental & Clinical Cancer Research, January 2010, Springer Science + Business Media

    Prof james O'Beirne

  199. Primary biliary cirrhosis after liver transplantation: Influence of immunosuppression and human leukocyte antigen locus disparity

    Article • Liver Transplantation, January 2010, Wiley

    Prof james O'Beirne

  200. Use of thromboelastography PlateletMapping™ to monitor antithrombotic therapy in a patient with Budd-Chiari syndrome

    Article • Liver Transplantation, January 2010, Wiley

    Prof james O'Beirne

  201. Adrenal Insufficiency

    Article • January 2010, Springer Science + Business Media

    Prof james O'Beirne

  202. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy

    Article • Liver Transplantation, December 2009, Wiley

    Prof james O'Beirne

  203. A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation

    Article • Journal of Viral Hepatitis, November 2009, Wiley

    Prof james O'Beirne

  204. RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit

    Article • Journal of Gastroenterology and Hepatology, October 2009, Wiley

    Prof james O'Beirne

  205. Response

    Article • Gastrointestinal Endoscopy, August 2009, Elsevier

    Prof james O'Beirne

  206. Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality

    Article • European Journal of Gastroenterology & Hepatology, July 2009, Wolters Kluwer Health

    Prof james O'Beirne

  207. Inhibition of major histocompatibility complex Class I antigen presentation by hepatitis C virus core protein in myeloid dendritic cells

    Article • Virology, June 2009, Elsevier

    Prof james O'Beirne

  208. 478 RECURRENCE PRIMARY BILIARY CIRRHOSIS AFTER LIVER TRANSPLANTATION: THE EFFECT OF AZATHIOPRINE

    Article • Journal of Hepatology, April 2009, Elsevier

    Prof james O'Beirne

  209. 212 USE OF THE SX-ELLA SELF-EXPANDING MESH METAL STENT IN THE MANAGEMENT OF COMPLEX VARICEAL HAEMORRHAGE: INITIAL EXPERIENCE IN A SINGLE CENTRE

    Article • Journal of Hepatology, April 2009, Elsevier

    Prof james O'Beirne

  210. Recurrent bacteremia due to retained embolized glue following variceal obliteration

    Article • Endoscopy, March 2009, Thieme Publishing Group

    Prof james O'Beirne

  211. Predictors of early rebleeding and mortality after acute variceal hemorrhage in patients with cirrhosis

    Article • Nature Clinical Practice Gastroenterology &#38 Hepatology, December 2008, Springer Science + Business Media

    Prof james O'Beirne

  212. Significant small-bowel lesions detected by alternative diagnostic modalities after negative capsule endoscopy

    Article • Gastrointestinal Endoscopy, December 2008, Elsevier

    Prof james O'Beirne

  213. Computer-assisted image analysis of liver collagen: Relationship to Ishak scoring and hepatic venous pressure gradient

    Article • Hepatology, November 2008, Wiley

    Prof james O'Beirne

  214. A removable covered self-expanding metal stent for the management of Sengstaken-Blakemore tube–induced esophageal tear and variceal hemorrhage

    Article • Gastrointestinal Endoscopy, October 2008, Elsevier

    Prof james O'Beirne

  215. Liver collagen proportionate area and hepatic venous pressure gradient to sub-classify cirrhosis: Proof of concept in HCV-infected liver transplant recipients with allograft cirrhosis

    Article • Digestive and Liver Disease, October 2008, Elsevier

    Prof james O'Beirne

  216. Clinical outcome of HCV-related graft cirrhosis and prognostic value of hepatic venous pressure gradient

    Article • Transplant International, September 2008, Wiley

    Prof james O'Beirne

  217. Prognostic models in cirrhotics admitted to intensive care units better predict outcome when assessed at 48 h after admission

    Article • Journal of Gastroenterology and Hepatology, August 2008, Wiley

    Prof james O'Beirne

  218. False-Positive Presentation of Battle’s Sign During Hepatic Encephalopathy

    Article • Neurocritical Care, June 2008, Springer Science + Business Media

    Prof james O'Beirne

  219. Incidence of adrenal dysfunction in cirrhosis

    Article • Journal of Hepatology, June 2008, Elsevier

    Prof james O'Beirne

  220. Systemic Therapy for Hepatocellular Carcinoma: Cytotoxic Chemotherapy, Targeted Therapy and Immunotherapy

    Article • Annals of Surgical Oncology, January 2008, Springer Science + Business Media

    Prof james O'Beirne

  221. 109 CORRELATION OF LIVER “COLLAGEN PROPORTIONATE AREA” BY COMPUTER ASSISTED IMAGE ANALYSIS AND HEPATIC VENOUS PRESSURE GRADIENT IN PATIENTS WITH RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTATION

    Article • Journal of Hepatology, January 2008, Elsevier

    Prof james O'Beirne

  222. 226 IMPACT OF ETHNICITY ON OUTCOME FOLLOWING LIVER TRANSPLANT (LT)-AN ANALYSIS OF PRETRANSPLANT VARIABLES

    Article • Journal of Hepatology, January 2008, Elsevier

    Prof james O'Beirne

  223. Adrenal insufficiency in liver disease – What is the evidence?

    Article • Journal of Hepatology, September 2007, Elsevier

    Prof james O'Beirne

  224. Prognostic impact of lactate in acute liver failure

    Article • Liver Transplantation, January 2007, Wiley

    Prof james O'Beirne

  225. The role of infection and inflammation in the pathogenesis of hepatic encephalopathy and cerebral edema in acute liver failure

    Article • Nature Clinical Practice Gastroenterology &#38 Hepatology, March 2006, Springer Science + Business Media

    Prof james O'Beirne

  226. Acute Liver Failure

    Article • January 2006, Elsevier

    Prof james O'Beirne

  227. Associated Systemic Conditions

    Article • January 2006, Elsevier

    Prof james O'Beirne

  228. Current management of the hepatorenal syndrome

    Article • Hepatology Research, August 2005, Elsevier

    Prof james O'Beirne

  229. Progression of collagenous colitis to Crohn??s disease

    Article • European Journal of Gastroenterology & Hepatology, May 2005, Wolters Kluwer Health

    Prof james O'Beirne

  230. Liver support

    Article • The International Journal of Artificial Organs, May 2005, SAGE Publications

    Prof james O'Beirne

  231. RE: El-Banayosy A, Kizner, L, Shcueler V, Bergmeier S, Dobaugh D, Koerfer R: First use of molecular adsorbent recirculation system technique in patients with hypoxic liver failure after cardiogenic shock. ASAIO J 50; 332???337, 2004.

    Article • ASAIO Journal, January 2005, Wolters Kluwer Health

    Prof james O'Beirne

  232. The role of the immune system in the control of hepatocellular carcinoma

    Article • European Journal of Gastroenterology & Hepatology, December 2004, Wolters Kluwer Health

    Prof james O'Beirne

  233. Management of Cirrhosis and Ascites

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 2004, New England Journal of Medicine (NEJM/MMS)

    Prof james O'Beirne

  234. Methicillin-resistant staphylococcus aureus - associated colitis, a potentially life threatening illness, may present with a number of clinical features similar to clostridium difficile - associated colitis

    Article • The American Journal of Gastroenterology, September 2002, Wolters Kluwer Health

    Prof james O'Beirne

  235. Cholestatic hepatitis in association with celecoxib

    Article • BMJ, July 2002, BMJ

    Prof james O'Beirne

  236. Interaction between warfarin and topical miconazole cream

    Article • BMJ, July 2002, BMJ

    Prof james O'Beirne

  237. Cholestatic hepatitis in association with celecoxib

    Article • BMJ, July 2001, BMJ

    Prof james O'Beirne

  238. Alcoholic hepatitis---the case for intensive management

    Article • Postgraduate Medical Journal, August 2000, BMJ

    Prof james O'Beirne

  239. BG9719 (CVT-124) a highly potent adenosine A-1 receptor antagonist. Initial experience in cirrhotic patients with diuretic refractory ascites

    Article • Gastroenterology, April 2000, Elsevier

    Prof james O'Beirne

  240. MYCOPHENOLATE MOFETIL MONOTHERAPY IN STABLE LIVER TRANSPLANT PATIENTS WITH CYCLOSPORINE-INDUCED RENAL IMPAIRMENT

    Article • Transplantation, July 1999, Wolters Kluwer Health

    Prof james O'Beirne